Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alexopoulos

Showing results (331-340 of 381) with videos related to

Pageof 39
Sort By:
Biological Psychiatry|November 25, 2006
White-matter integrity predicts stroop performance in patients with geriatric depressionChristopher F Murphy, Faith M Gunning-Dixon, Matthew J Hoptman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 2, 2008
Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging studyFaith M Gunning-Dixon, Matthew J Hoptman, Kelvin O Lim, et al.
Epidemiology (Cambridge, Mass.)|December 13, 2012
Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideationStephen E Gilman, Garrett M Fitzmaurice, Martha L Bruce, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
Journal of Affective Disorders|September 22, 2018
White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary studyLindsay W Victoria, George S Alexopoulos, Irena Ilieva, et al.
Molecular Psychiatry|March 20, 2024
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic featuresHelena K Kim, Aristotle N Voineskos, Nicholas H Neufeld, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 3, 2020
Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II StudyAlastair J Flint, Anthony J Rothschild, Ellen M Whyte, et al.
Pageof 39

Showing results (331-340 of 381) with videos related to

Sort By:
Pageof 39
Biological Psychiatry|November 25, 2006
White-matter integrity predicts stroop performance in patients with geriatric depressionChristopher F Murphy, Faith M Gunning-Dixon, Matthew J Hoptman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 2, 2008
Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging studyFaith M Gunning-Dixon, Matthew J Hoptman, Kelvin O Lim, et al.
Epidemiology (Cambridge, Mass.)|December 13, 2012
Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideationStephen E Gilman, Garrett M Fitzmaurice, Martha L Bruce, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
Journal of Affective Disorders|September 22, 2018
White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary studyLindsay W Victoria, George S Alexopoulos, Irena Ilieva, et al.
Molecular Psychiatry|March 20, 2024
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic featuresHelena K Kim, Aristotle N Voineskos, Nicholas H Neufeld, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 3, 2020
Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II StudyAlastair J Flint, Anthony J Rothschild, Ellen M Whyte, et al.
Pageof 39